Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104402803A details high-yield L-high proline synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Novel low-temperature halogenated solvent process for high-purity imidazole ester. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Patent CN102936214B details a green synthesis of H acid using mother liquor recycling and hydrogenation, reducing waste by over 80% for reliable dye intermediate supply.
Advanced synthesis of triacetyl ganciclovir via monoacetyl guanine condensation. Superior purity, reduced isomers, and cost-effective manufacturing for global pharmaceutical supply chains.
Novel bromine-positioning synthesis route ensures greater than 99.5 percent purity for OLED and pharma intermediates, solving stability issues.
Novel patent CN112624981B details a high-yield route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of difluorodichlorobenzimide via halogen exchange. High-purity reference standards for levofloxacin intermediates. Cost-effective manufacturing solutions.
Advanced Pd-catalyzed synthesis of ortho-deuterated benzoic acid derivatives. High selectivity, recyclable directing groups, and scalable manufacturing for pharmaceutical intermediates.
Novel nickel-catalyzed route for Bilastine key intermediate reduces toxicity and cost, offering a scalable supply chain solution for global pharmaceutical manufacturers.
Novel synthesis method for Buparvaquone intermediate ensures high purity and scalable production for global veterinary pharmaceutical supply chains reducing manufacturing complexity.
Novel green synthesis route for DL-alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone offering high yield and purity for vitamin B5 manufacturing supply chains.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.